Plasma miRNAs as Potential Early Biomarkers for Acute Cardiac Injury Webinar
Drug‑induced cardiac injury (DICI) detection remains a major safety issue in drug development
Join Dr Stéphanie Glineur of Union Chimique Belge (UCB) as she review their recent acute DICI toxcity study comparing miR208a 3p and CTnT and CTnl, and discuss the future use of plasma miRNAs as early biomarkers for acute cardiac injury.
About the Presenter
Dr Stéphanie Glineur holds a DVM and a PhD degree in Veterinary Sciences from the University of Liege (Belgium) and completed a 2.5 year post-doctoral fellowship at the National Institutes of Health in Bethesda (MD, USA). During her professional career, Stéphanie developed a deep expertise in immuno-pathology, genetics and molecular biology.
Stéphanie has over 10 years research experience, including the last 2 years as responsible for microRNA safety biomarker implementation and as a key contributor to mechanistic and investigative toxicology in drug development. She is currently lecturer in Animal Genetics at the Université libre de Bruxelles.
- Acute DICI toxicity study
- Identification of plasma miRs as potential biomarkers
- Performance comparison between miR208a 3p and cTnT and cTnI
- Conclusions and Future Directions